Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Mechanical thrombectomy was associated with better survival outcomes across patient risk categories and time-to-treatment.

Exacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and ...

Krunal Patel, MD, Temple University Hospital, highlights CHEST 2024 data revealing why timing matters with acute pulmonary embolism (PE) intervention.

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

The following is a summary of “Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease ...

Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Acute kidney failure, now known as ...

The prevalence of PH was 12.8% in those hospitalized in 2018 with left heart disease, a lower percentage than found in previous research.

A higher abundance of monocyte-derived alveolar macrophages significantly correlated with worse lung fibrosis in RPRA ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and pre-existing respiratory conditions, including COPD and OSA.

Non-vitamin K oral anticoagulants (NOACs) are a class of drugs that can treat and prevent blood clots. Learn more the ...